| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.03▲ | 8.92▲ | 8.99▲ | 9.06▲ | 9.37▼ |
| MA10 | 8.98▲ | 8.98▲ | 8.90▲ | 9.10▼ | 9.34▼ |
| MA20 | 8.91▲ | 8.86▲ | 8.89▲ | 9.27▼ | 15.04▼ |
| MA50 | 8.96▲ | 8.89▲ | 8.99▲ | 9.29▼ | 17.42▼ |
| MA100 | 8.88▲ | 8.99▲ | 9.10▼ | 16.05▼ | N/A |
| MA200 | 8.86▲ | 9.12▼ | 9.50▼ | 18.70▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.027▲ | 0.014▲ | 0.031▲ | 0.016▲ | -0.433▼ |
| RSI | 62.484▲ | 58.316▲ | 54.558▲ | 45.127▼ | 35.069▼ |
| STOCH | 85.192▲ | 38.964 | 72.201 | 45.053 | 50.756 |
| WILL %R | -14.062▲ | -14.103▲ | -39.267 | -48.899 | -91.372▼ |
| CCI | 129.290▲ | 98.687 | 95.238 | -116.560▼ | -25.354 |
|
Wednesday, May 13, 2026 04:22 AM
Company rapidly advancing Phase 3 programs designed to deliver best-in-class efficacy with convenient quarterly dosing in severe asthma and CRSwNP – – End-of-Phase 2 meetings with FDA planned for ...
|
|
Tuesday, April 14, 2026 12:48 PM
On Tuesday, Upstream Bio (NASDAQ:UPB) received a positive outlook from TD Cowen, as the firm started coverage on the biotech... ByInvesting.com • 05 Nov 2024 Piper Sandler sees big potential for ...
|
|
Tuesday, April 14, 2026 12:48 PM
On Tuesday, Upstream Bio (NASDAQ:UPB) received a positive outlook from TD Cowen, as the firm started coverage on the biotech ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/05/26 | 8.59 | 9.14 | 8.55 | 9.09 | 979,800 |
| 14/05/26 | 9.45 | 9.518 | 8.51 | 8.79 | 562,495 |
| 13/05/26 | 8.96 | 9.46 | 8.805 | 9.36 | 815,500 |
| 12/05/26 | 8.93 | 9.14 | 8.83 | 8.95 | 459,058 |
| 11/05/26 | 9.20 | 9.595 | 9.05 | 9.11 | 363,959 |
| 08/05/26 | 8.88 | 9.35 | 8.8001 | 9.09 | 449,303 |
| 07/05/26 | 9.14 | 9.14 | 8.69 | 8.985 | 255,716 |
| 06/05/26 | 9.16 | 9.29 | 8.98 | 9.19 | 409,160 |
| 05/05/26 | 9.31 | 9.50 | 8.88 | 9.12 | 251,700 |
| 04/05/26 | 9.34 | 9.56 | 9.16 | 9.31 | 300,447 |
|
|
||||
|
|
||||
|
|